Search research articles
Contact Us
Filters
Showing results (71-80 of 95) with videos related to
Page
of 10
Sort By:
Frontiers in Immunology
|
September 26, 2019
Expression of CD38 on Macrophages Predicts Improved Prognosis in Hepatocellular Carcinoma
Jian Hang Lam, Harry Ho Man Ng, Chun Jye Lim, et al.
Nature Communications
|
February 28, 2017
The spatial organization of intra-tumour heterogeneity and evolutionary trajectories of metastases in hepatocellular carcinoma
Weiwei Zhai, Tony Kiat-Hon Lim, Tong Zhang, et al.
Frontiers in Immunology
|
June 21, 2023
Immunohistochemical scoring of LAG-3 in conjunction with CD8 in the tumor microenvironment predicts response to immunotherapy in hepatocellular carcinoma
Chun Chau Lawrence Cheung, Yong Hock Justin Seah, Juntao Fang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 27, 2018
Real-Time Tumor Gene Expression Profiling to Direct Gastric Cancer Chemotherapy: Proof-of-Concept "3G" Trial
Wei Peng Yong, Sun Young Rha, Iain Bee-Huat Tan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 16, 2022
Multi-omic Characterization of Pancreatic Ductal Adenocarcinoma Relates CXCR4 mRNA Expression Levels to Potential Clinical Targets
Florian Kocher, Alberto Puccini, Gerold Untergasser, et al.
Liver Cancer
|
July 8, 2016
National Cancer Centre Singapore Consensus Guidelines for Hepatocellular Carcinoma
Pierce K H Chow, Su Pin Choo, David C E Ng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 29, 2018
Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients with <i>RAS</i>-Mutated Hepatocellular Carcinoma
Ho Yeong Lim, Philippe Merle, Karl Heinz Weiss, et al.
Ebiomedicine
|
July 19, 2016
Tissue Microbiome Profiling Identifies an Enrichment of Specific Enteric Bacteria in Opisthorchis viverrini Associated Cholangiocarcinoma
Kern Rei Chng, Sock Hoai Chan, Amanda Hui Qi Ng, et al.
Immunity
|
July 16, 2021
Non-terminally exhausted tumor-resident memory HBV-specific T cell responses correlate with relapse-free survival in hepatocellular carcinoma
Yang Cheng, Bavani Gunasegaran, Harsimran D Singh, et al.
The Lancet. Oncology
|
December 16, 2021
Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial
Thomas Yau, Joong-Won Park, Richard S Finn, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 95) with videos related to
Sort By:
Page
of 10
Frontiers in Immunology
|
September 26, 2019
Expression of CD38 on Macrophages Predicts Improved Prognosis in Hepatocellular Carcinoma
Jian Hang Lam, Harry Ho Man Ng, Chun Jye Lim, et al.
Nature Communications
|
February 28, 2017
The spatial organization of intra-tumour heterogeneity and evolutionary trajectories of metastases in hepatocellular carcinoma
Weiwei Zhai, Tony Kiat-Hon Lim, Tong Zhang, et al.
Frontiers in Immunology
|
June 21, 2023
Immunohistochemical scoring of LAG-3 in conjunction with CD8 in the tumor microenvironment predicts response to immunotherapy in hepatocellular carcinoma
Chun Chau Lawrence Cheung, Yong Hock Justin Seah, Juntao Fang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 27, 2018
Real-Time Tumor Gene Expression Profiling to Direct Gastric Cancer Chemotherapy: Proof-of-Concept "3G" Trial
Wei Peng Yong, Sun Young Rha, Iain Bee-Huat Tan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 16, 2022
Multi-omic Characterization of Pancreatic Ductal Adenocarcinoma Relates CXCR4 mRNA Expression Levels to Potential Clinical Targets
Florian Kocher, Alberto Puccini, Gerold Untergasser, et al.
Liver Cancer
|
July 8, 2016
National Cancer Centre Singapore Consensus Guidelines for Hepatocellular Carcinoma
Pierce K H Chow, Su Pin Choo, David C E Ng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 29, 2018
Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients with <i>RAS</i>-Mutated Hepatocellular Carcinoma
Ho Yeong Lim, Philippe Merle, Karl Heinz Weiss, et al.
Ebiomedicine
|
July 19, 2016
Tissue Microbiome Profiling Identifies an Enrichment of Specific Enteric Bacteria in Opisthorchis viverrini Associated Cholangiocarcinoma
Kern Rei Chng, Sock Hoai Chan, Amanda Hui Qi Ng, et al.
Immunity
|
July 16, 2021
Non-terminally exhausted tumor-resident memory HBV-specific T cell responses correlate with relapse-free survival in hepatocellular carcinoma
Yang Cheng, Bavani Gunasegaran, Harsimran D Singh, et al.
The Lancet. Oncology
|
December 16, 2021
Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial
Thomas Yau, Joong-Won Park, Richard S Finn, et al.
Page
of 10